FDAFDA · Food and drugs·Recall number D-0616-2018
Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.
Published April 11, 2018 · Recall initiated: March 21, 2018
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- FABIOR
- Manufacturer
- Mayne Pharma Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot: MBEB, Exp. 01/31/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.